文献速递炎症性肠病消化道肿瘤与早癌消化内镜

开启精准医学之门:评估炎症性肠病与结肠炎相关肿瘤中肠道屏障的新工具

Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia.
PubMed 文献 · Gut · 2024-09-09

综述指出肠道屏障及其与饮食、肠道微生物组的复杂网络在炎症性肠病(IBD)和结肠炎相关结直肠癌(CRC)发病中起关键作用,屏障愈合是重要治疗靶点。超高清内镜细胞术、探针共聚焦激光显微内镜等新型内镜成像及多光谱成像、上转换纳米粒子、数字空间分析等空间成像技术可实时评估细胞、分子和超微结构屏障,人工智能有助于标准化和整合这些工具。未来综合方法有望发现新治疗靶点、突破IBD治疗天花板。

要点

  • 肠道屏障与饮食、肠道微生物组的复杂网络在IBD和结肠炎相关CRC发病中起关键作用。
  • 屏障评估可预测疾病结局、治疗反应和肠外表现,屏障愈合是重要治疗靶点。
  • 超高清内镜细胞术和探针共聚焦激光显微内镜可实时探索细胞屏障,人工智能有助于标准化和整合新工具。

核心结论

  • 综合评估肠道屏障的新技术有望发现新治疗靶点,突破IBD治疗天花板,并推动IBD的变革性和个性化管理。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 肠道屏障与饮食和肠道微生物组的复杂网络在IBD和结肠炎相关CRC发病中起关键作用。
  • 肠道屏障与肝脏和大脑的双向关联(肠-脑轴)在IBD肠外表现和CRC转移等并发症中起关键作用。
  • 超高清内镜细胞术和探针共聚焦激光显微内镜可实时探索细胞肠道屏障。
  • 多光谱成像、上转换纳米粒子、数字空间分析、光学光谱和质谱流式等空间成像技术平台可深入全面评估分子和超微结构屏障。
  • 人工智能在标准化和整合这些新工具中起关键作用,有助于屏障评估和结局预测。

关键数值与推荐

  • 新型分子、饮食干预和微生物组调节策略旨在恢复、强化或调节肠-脑轴。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mounting evidence underscores the pivotal role of the intestinal barrier and its convoluted network with diet and intestinal microbiome in the pathogenesis of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CRC). Moreover, the bidirectional association of the intestinal barrier with the liver and brain, known as the gut-brain axis, plays a crucial role in developing complications, including extraintestinal manifestations of IBD and CRC metastasis. Consequently, barrier healing represents a crucial therapeutic target in these inflammatory-dependent disorders, with barrier assessment predicting disease outcomes, response to therapy and extraintestinal manifestations.New advanced technologies are revolutionising our understanding of the barrier paradigm, enabling the accurate assessment of the intestinal barrier and aiding in unravelling the complexity of the gut-brain axis. Cutting-edge endoscopic imaging techniques, such as ultra-high magnification endocytoscopy and probe-based confocal laser endomicroscopy, are new technologies allowing real-time exploration of the 'cellular' intestinal barrier. Additionally, novel advanced spatial imaging technology platforms, including multispectral imaging, upconversion nanoparticles, digital spatial profiling, optical spectroscopy and mass cytometry, enable a deep and comprehensive assessment of the 'molecular' and 'ultrastructural' barrier. In this promising landscape, artificial intelligence plays a pivotal role in standardising and integrating these novel tools, thereby contributing to barrier assessment and prediction of outcomes.Looking ahead, this integrated and comprehensive approach holds the promise of uncovering new therapeutic targets, breaking the therapeutic ceiling in IBD. Novel molecules, dietary interventions and microbiome modulation strategies aim to restore, reinforce, or modulate the gut-brain axis. These advancements have the potential for transformative and personalised approaches to managing IBD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Iacucci M, Santacroce G, Majumder S, et al. Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia. Gut. 2024. PMID: 38851294. doi:10.1136/gutjnl-2023-331579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。